Community Clinical Oncology Program

The summary for the Community Clinical Oncology Program grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Community Clinical Oncology Program: The Division of Cancer Prevention (DCP), National Cancer Institute (NCI), invites domestic institutions to apply for cooperative agreements in response to this Community Clinical Oncology Program (CCOP) Request for Applications (RFA). Applicants for new and currently funded Community Clinical Oncology Programs (CCOP) and research bases are invited to respond to this RFA. Using the national resource of highly trained oncologists in community practice, the CCOP: 1) provides support for expanding the clinical research effort in the community setting; 2) stimulates quality care in the community through participation in protocol studies; 3) fosters the growth and development of a scientifically viable community cancer network able to work closely with NCI-supported clinical cooperative groups and cancer centers; 4) supports development of and community participation in cancer prevention and control intervention research, which includes chemoprevention, biomarkers and early detection, symptom management, quality of life, rehabilitation, and continuing care research; 5) involves primary care providers and other specialists in cancer prevention and control clinical trials; and 6) increases the involvement of minority and underserved populations in clinical research. Combining the expertise of community physicians and other health care professionals with NCI-approved cancer treatment and prevention and control clinical trials provides the opportunity for the transfer of the latest research findings to the community level. The NCI-supported clinical cooperative groups and/or cancer centers serve as research bases for the CCOPs. These research bases design the protocols for the clinical trials in cancer treatment, prevention and early detection as well as evaluating interventions affecting quality of life, rehabilitation and symptom management associated with cancer and its treatment. In addition, research bases manage and analyze all data collected and monitor data quality and subject accrual. The research bases seek to define the key unanswered questions in cancer and then conduct clinical trials to answer these questions. This reissuance of the CCOP RFA seeks to build on the strength and demonstrated success of the CCOP network over the past twenty years by: 1) continuing the program as a vehicle for supporting community participation in cancer treatment and prevention and control clinical trials through research bases (clinical cooperative groups and cancer centers supported by NCI); 2) expanding and strengthening the cancer prevention and control research effort; 3) utilizing the CCOP network for conducting NCI-assisted cancer prevention and control research; and 4) evaluating on a continuing basis CCOP performance and its impact in the community.
Federal Grant Title: Community Clinical Oncology Program
Federal Agency Name: National Institutes of Health
Grant Categories: Health Education
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-CA-04-008
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.399
CFDA Descriptions: Cancer Control
Current Application Deadline: No deadline provided
Original Application Deadline: Jul 14, 2003
Posted Date: Jun 05, 2003
Creation Date: Aug 13, 2003
Archive Date: Aug 13, 2003
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
State governments County governments City or township governments Special district governments Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses Small businesses Others (see text field entitled "Additional Information on Eligibility" for clarification)
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster OERWebmaster@od.nih.gov NIH OER Webmaster
Similar Government Grants
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R...
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R...
HLA and KIR Region Genomics in Immune-Mediated Diseases (U01 Clinical Trial Not Allowed)
Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinar...
Research Infrastructure Development for Interdisciplinary Aging Studies (R21/R33 - Clinica...
Exploratory Grants for Behavioral Research in Cancer Control
Decision Making in Cancer: Single-Event Decisions
Small Grants for Behavioral Research in Cancer Control (R03)
More Grants from the National Institutes of Health
Limited Competition: Exploratory and Developmental Research Grant Program for NIAID K01/K0...
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R...
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R...
Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R03 Clinica...
NIDA Program Project Grant Applications (P01 Clinical Trial Optional)

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2019 FederalGrants.com